CorMedix Inc. (CRMD)
NASDAQ: CRMD · IEX Real-Time Price · USD
5.37
-0.15 (-2.72%)
At close: May 2, 2024, 4:00 PM
5.33
-0.04 (-0.73%)
Pre-market: May 3, 2024, 8:00 AM EDT
CorMedix Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
82
Market Cap
295.25M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 65.41K | -125.53K | -65.74% |
Dec 31, 2021 | 190.94K | -48.30K | -20.19% |
Dec 31, 2020 | 239.23K | -44.04K | -15.55% |
Dec 31, 2019 | 283.27K | -146.53K | -34.09% |
Dec 31, 2018 | 429.80K | 100.47K | 30.51% |
Dec 31, 2017 | 329.33K | 105.22K | 46.95% |
Dec 31, 2016 | 224.11K | 13.98K | 6.65% |
Dec 31, 2015 | 210.13K | 20.86K | 11.02% |
Dec 31, 2014 | 189.27K | 187.27K | 9,358.97% |
Dec 31, 2013 | 2.00K | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Dec 31, 2010 | 0 | - | - |
Dec 31, 2009 | 0 | - | - |
Dec 31, 2008 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Procaps Group | 414.10M |
Kamada | 142.52M |
Nektar Therapeutics | 90.12M |
Enanta Pharmaceuticals | 73.62M |
Pulmonx | 68.68M |
Verrica Pharmaceuticals | 5.12M |
XOMA Corporation | 4.76M |
Inovio Pharmaceuticals | 832.01K |
CRMD News
- 13 days ago - CorMedix Inc. Announces CMS Grants TDAPA to DefenCath - GlobeNewsWire
- 17 days ago - CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) - GlobeNewsWire
- 21 days ago - CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference - GlobeNewsWire
- 24 days ago - CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC - GlobeNewsWire
- 7 weeks ago - CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024 - GlobeNewsWire
- 3 months ago - CorMedix Inc. Announces Commercial and Reimbursement Updates - GlobeNewsWire
- 4 months ago - CorMedix Inc. Announces Commercial and Operational Updates - GlobeNewsWire